10-gene biomarker that could predict whether colon cancer patients will benefit from adjuvant chemotherapy – Sylvester Comprehensive Cancer Center

Sylvester Comprehensive Cancer Center shared on LinkedIn:

“We are proud to share that Sylvester’s Dr. Steven Chen has led a study published in Cell Press. This study identifies and validates a 10-gene biomarker that could predict whether colon cancer patients will benefit from adjuvant chemotherapy.

This finding sets the stage for more personalized treatment decisions in the future. Learn how Dr. Chen and his team are advancing precision oncology.”

Source: Sylvester Comprehensive Cancer Center/LinkedIn